Aspiring to realize the world’s highest medical safety standards with the latest technology, Thoracentes, Inc. (HQ: Bunkyo-ku, Tokyo; CEO: Kenji Suzuki, M.D., Ph.D.) procured a total amount of 500 million yen by allocating new shares to third parties including Creek and River Inc. (HQ: Minato-ku, Tokyo; Chairperson and Representative Director (CEO): Yukihiro Ikawa) and Internet Initiative Japan Inc. (HQ: Chiyoda-ku, Tokyo; Chairman and Co-CEO: Koichi Suzuki).

With the world’s first innovative medical devices based on mixed reality, Thoracentes, Inc. seeks to foster the development of clinical medicine and improve the quality, safety, and reliability of medical care worldwide.